Search

everythinglearnresearchcommunity

for

Search:↓

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Hair changes can indicate systemic diseases or medication effects.

Finasteride changes antioxidant enzyme expression, possibly affecting sperm protection in rats.

Dogs with sex hormone imbalances may not drink or pee a lot but often lose hair on their body and can have reproductive system issues.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

pH changes are crucial for root hair growth because they affect enzymes and proteins that control the cell wall and growth.

Omega-6 fats in certain cells boost male hormone production.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Seasonal changes affect gene activity linked to hair growth in Angora goats, influencing mohair quality.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Some drugs can cause changes to your hair.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Addressing skin changes during pregnancy is important to reduce stress for expectant mothers.

Vav2 changes how hair follicle stem cells' genes work as they age, which might improve regeneration but also raise cancer risk.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.